Registration of a “UK Authorised Representative” successfully completed.
In order to continue operating on the UK market after Brexit, we as manufacturers of medical devices bearing the UKCA label must appoint an authorized representative for the UK starting from July 1, 2023.
Many of our competitors have decided not to undergo this registration, as the new regulations – particularly those relating to product labeling and documentation – entail a considerable amount of work. We have decided to continue our operations in Great Britain and Northern Ireland. We have already concluded the necessary contract with an authorized representative, which means our full range of products and services remains available to customers from the British Isles.
Do you have any questions or require specific information? If so, please do not hesitate to contact us.
